Subtype
Malignant Reproductive System Neoplasm
CI-CAN-00001172Explore in graph →
2,804 active trials38 approved drugs186 evidence items
- NCIt
- C36076
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00001172Explore in graph →
Clinical trials
12,158 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,473)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00032058 | Magnetic Resonance Imaging and Magnetic Resonance Spectroscopic Imaging in Diagnosing the Extent of Disease in Patients With Prostate Cancer | completed | N/A | — | American College of Radiology Imaging NetworkNETWORK | 1 | Feb 21, 2011 | clinicaltrials |
| NCT00046943 | Atrasentan in Treating Patients With Prostate Cancer | completed | Phase 3 | — | AbbottINDUSTRY | 1 | Feb 21, 2011 | clinicaltrials |
| NCT00316407 | Lapatinib/Carboplatin/Paclitaxel in Previously Treated Ovarian or Breast Cancer Patients | completed | Phase 1 / Phase 2 | 30 | Swedish Medical CenterOTHER | 1 | Feb 18, 2011 | clinicaltrials |
| NCT00368420 | Validation of a Score of Predictive Factors for Complete Resection in Platinum-sensitive Recurrent Ovarian Cancer | completed | — | 122 | AGO Study GroupOTHER | 4 | Feb 15, 2011 | clinicaltrials |
| NCT00987649 | Ovarian Cancer Risk Estimation in Patients With Pelvic Mass | completed | — | 512 | Fujirebio Diagnostics, Inc.INDUSTRY | 1 | Feb 9, 2011 | clinicaltrials |
| NCT00834392 | Exercise in Men With Prostate Cancer | completed | N/A | 30 | University of ManitobaOTHER | 1 | Feb 1, 2011 | clinicaltrials |
| NCT00856102 | Exercise and Cognitive-psychosocial Functions in Men With Prostate Cancer Receiving Androgen Depletion Therapy | completed | N/A | 30 | University of ManitobaOTHER | 1 | Feb 1, 2011 | clinicaltrials |
| NCT00004091 | Detection of Biomarkers in Abnormal Cervical Cells in Women With Abnormal Pap Test Results | completed | — | 100 | Northwestern UniversityOTHER | 1 | Jan 31, 2011 | clinicaltrials |
| NCT00233610 | Two Different Regimens of Nolvadex in Preventing Gynecomastia Induced by Casodex 150 mg in Patients With Prostate Cancer | completed | Phase 3 | 180 | AstraZenecaINDUSTRY | 1 | Jan 27, 2011 | clinicaltrials |
| NCT00562003 | Safety Study of a Genetically Modified Adenovirus in Ovarian Cancer Patients(Ad5Delta24RGD) | completed | Phase 1 | 26 | University of Alabama at BirminghamOTHER | 1 | Jan 26, 2011 | clinicaltrials |
| NCT00319787 | Combination Casodex® and Iressa™ in Locally Advanced Prostate Cancer | completed | Phase 2 | 102 | AstraZenecaINDUSTRY | 1 | Jan 25, 2011 | clinicaltrials |
| NCT00326586 | A Phase I Dose-Escalation Study of BMS-641988 in Patients With Castration-Resistant Prostate Cancer | completed | Phase 1 | 54 | Bristol-Myers SquibbINDUSTRY | 1 | Jan 25, 2011 | clinicaltrials |
| NCT00644488 | A Phase I Study of BMS-641988 in Japanese Patients With Castration Resistant Prostate Cancer | completed | Phase 1 | 7 | Bristol-Myers SquibbINDUSTRY | 1 | Jan 25, 2011 | clinicaltrials |
| NCT00637871 | Casodex - Nolvadex Combination | completed | Phase 2 | — | AstraZenecaINDUSTRY | 0 | Jan 24, 2011 | clinicaltrials |
| NCT00502164 | Study to Assess Safety and Tolerability of AZD2171 After Multiple Doses in Patients With Advanced Prostate Cancer(AZD2171IL/0003) | completed | Phase 1 | 40 | AstraZenecaINDUSTRY | 1 | Jan 21, 2011 | clinicaltrials |
| NCT00003269 | Amifostine Followed by High Dose Chemotherapy in Treating Patients With Hematologic Cancer or Solid Tumors | completed | Phase 2 | 20 | Scripps HealthOTHER | 1 | Jan 10, 2011 | clinicaltrials |
| NCT00268892 | Extension Study Investigating the Long-Term Safety of Degarelix Three-Month Depots in Patients With Prostate Cancer | completed | Phase 2 / Phase 3 | 278 | Ferring PharmaceuticalsINDUSTRY | 10 | Dec 24, 2010 | clinicaltrials |
| NCT01258413 | Laparoscopic vs Abdominal Radical Hysterectomy In Patients With Early Cervical Cancer | completed | Phase 3 | 30 | Hospital Nossa Senhora da ConceicaoOTHER | 1 | Dec 24, 2010 | clinicaltrials |
| NCT00252941 | Prophylactic Urethral Stenting With Memokath After Prostate Implantation for Prostate Adenocarcinoma | completed | Phase 1 / Phase 2 | 20 | The Cleveland ClinicOTHER | 1 | Dec 21, 2010 | clinicaltrials |
| NCT00264420 | Safety and Efficacy Study of Concomitant Radiotherapy and Zoledronic Acid for Bone Metastases Palliation | completed | Phase 1 | 4 | The Cleveland ClinicOTHER | 0 | Dec 21, 2010 | clinicaltrials |
| NCT01262144 | SUV Max as Predictor of Outcome in Cervical Cancer | completed | — | 50 | Rambam Health Care CampusOTHER | 1 | Dec 17, 2010 | clinicaltrials |
| NCT00116753 | A Comparative Study of Degarelix Three-month Depot in Three Different Dosing Regimens in Patients With Prostate Cancer | completed | Phase 2 | 460 | Ferring PharmaceuticalsINDUSTRY | 11 | Dec 10, 2010 | clinicaltrials |
| NCT00668083 | Observational Retrospective Trial on Sequential Hormonal Therapy in Patients With Prostate Cancer(Sorse) | completed | — | 214 | AstraZenecaINDUSTRY | 1 | Dec 10, 2010 | clinicaltrials |
| NCT00692874 | Quality of Life Analysis of Treatment in Patients With Prostate Cancer on Adjuvant Zoladex Therapy(AZTEK EXT) | completed | — | 1,646 | AstraZenecaINDUSTRY | 1 | Dec 10, 2010 | clinicaltrials |
| NCT00579787 | Prospective Study Assessing Emotional, Sexual and Quality of Life Concerns Of Women Undergoing Removal of the Cervix Versus Removal of the Uterus,Ovaries and Fallopian Tubes For Treatment Of Early Stage Cervical Cancer | completed | — | 72 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Dec 2, 2010 | clinicaltrials |
| NCT01250483 | Effects of Alpha Blockers on Prostate-specific Antigen (PSA) Change in Men With Lower Urinary Tract Symptoms (LUTS) | completed | — | 174 | Seoul National University HospitalOTHER | 1 | Nov 30, 2010 | clinicaltrials |
| NCT00106392 | A Safety and Efficacy Study of Prograf in the Prevention of Erectile Dysfunction After Radical Prostatectomy | completed | Phase 4 | 131 | Astellas Pharma IncINDUSTRY | 1 | Nov 23, 2010 | clinicaltrials |
| NCT00741533 | Quality of Life in Thai Women Diagnosed Cervical Cancer at King Chulalongkorn Memorial Hospital | completed | — | 172 | Chulalongkorn UniversityOTHER | 1 | Nov 18, 2010 | clinicaltrials |
| NCT00002881 | Flutamide, Suramin, and Hydrocortisone in Treating Patients With Prostate Cancer | completed | Phase 3 | — | Eastern Cooperative Oncology GroupNETWORK | 1 | Nov 9, 2010 | clinicaltrials |
| NCT00816452 | Awareness to Osteopenia's Treatment by Bisphosphonate in Male Suffering From Prostate Cancer(InoPro) | completed | — | 180 | SanofiINDUSTRY | 1 | Nov 3, 2010 | clinicaltrials |
| NCT00005947 | Vaccine Therapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy | completed | Phase 3 | 127 | DendreonINDUSTRY | 1 | Nov 1, 2010 | clinicaltrials |
| NCT00340184 | A Safety and Efficacy of CCRT With Paclitaxel/Carboplatin as Adjuvant Therapy to Post-operative Cervical Cancer Patients | completed | Phase 2 | 55 | Korean Gynecologic Oncology GroupOTHER | 1 | Oct 19, 2010 | clinicaltrials |
| NCT00735150 | Awareness and Attitudes Regarding Prenatal and Preimplantation Genetic Diagnosis for Inherited Breast/Ovarian Cancer Risk | completed | — | 34 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Oct 11, 2010 | clinicaltrials |
| NCT00097409 | Ispinesib In Subjects With Platinum-Taxane-Refractory Or Resistant Relapsed Ovarian Cancer | completed | Phase 2 | 35 | GlaxoSmithKlineINDUSTRY | 1 | Oct 4, 2010 | clinicaltrials |
| NCT00002508 | Combination Chemotherapy Followed by Bone Marrow or Stem Cell Transplantation in Treating Patients With Relapsed or Refractory Germ Cell Tumors | completed | Phase 1 / Phase 2 | — | Temple UniversityOTHER | 1 | Oct 1, 2010 | clinicaltrials |
| NCT00003598 | UMCC 9609 Tretinoin in Preventing Cancer of the Cervix in Patients With Cervical Neoplasia(IRB 1996-0189) | completed | N/A | 180 | University of Michigan Rogel Cancer CenterOTHER | 1 | Sep 22, 2010 | clinicaltrials |
| NCT00082654 | Study of the Emotional Needs of Caregivers of Stem Cell Transplantation Patients | completed | N/A | — | Fred Hutchinson Cancer CenterOTHER | 1 | Sep 21, 2010 | clinicaltrials |
| NCT00217529 | Erlotinib, Docetaxel, and Carboplatin in Treating Patients With Newly Diagnosed Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube Cancer | completed | Phase 1 / Phase 2 | — | Fred Hutchinson Cancer CenterOTHER | 1 | Sep 21, 2010 | clinicaltrials |
| NCT00217555 | Gemcitabine and Topotecan in Treating Patients With Recurrent or Persistent Ovarian, Fallopian Tube, or Primary Peritoneal Cavity Cancer | completed | Phase 2 | — | Fred Hutchinson Cancer CenterOTHER | 1 | Sep 21, 2010 | clinicaltrials |
| NCT00217568 | Docetaxel and Carboplatin in Treating Patients With Relapsed Stage III or Stage IV Ovarian Epithelial or Primary Peritoneal Cavity Cancer | completed | Phase 2 | — | Fred Hutchinson Cancer CenterOTHER | 1 | Sep 21, 2010 | clinicaltrials |
| NCT00541788 | Evaluation of the Efficacy and Safety of Common Sage in Controlling Hot Flashes in Prostate Cancer Patients Treated by Androgen Deprivation | completed | Phase 1 | 10 | University Hospital, GhentOTHER | 1 | Sep 17, 2010 | clinicaltrials |
| NCT00002977 | Melphalan and Thiotepa Followed by Peripheral Stem Cell Transplantation in Treating Patients With Epithelial Ovarian Cancer in Complete Remission | completed | Phase 1 | 45 | Fred Hutchinson Cancer CenterOTHER | 1 | Sep 15, 2010 | clinicaltrials |
| NCT00003080 | Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Persistent or Platinum Refractory Stage III or IV Ovarian Cancer | completed | Phase 1 | — | Fred Hutchinson Cancer CenterOTHER | 1 | Sep 15, 2010 | clinicaltrials |
| NCT00598312 | Safety and Efficacy Study of Leuprolide Acetate for Injectable Suspension 22.5 MG in the Treatment of Prostate Cancer | completed | Phase 3 | 201 | Oakwood Laboratories, LLCINDUSTRY | 1 | Sep 8, 2010 | clinicaltrials |
| NCT00065442 | Provenge® (Sipuleucel-T) Active Cellular Immunotherapy Treatment of Metastatic Prostate Cancer After Failing Hormone Therapy | completed | Phase 3 | 512 | DendreonINDUSTRY | 2 | Sep 6, 2010 | clinicaltrials |
| NCT00201916 | Shorter Radiation Schedule for the Treatment of Prostate Cancer | completed | Phase 3 | 936 | Ontario Clinical Oncology Group (OCOG)OTHER | 1 | Aug 17, 2010 | clinicaltrials |
| NCT00004014 | Liposomal Doxorubicin in Treating Patients With Prostate Cancer | completed | Phase 2 | 10 | Case Comprehensive Cancer CenterOTHER | 1 | Aug 16, 2010 | clinicaltrials |
| NCT00900679 | Effects of a Teaching Intervention With an Advanced Practice Nurse on Quality of Life and Psychosocial and Symptom Distress in Patients With Ovarian Cancer | completed | N/A | 110 | City of Hope Medical CenterOTHER | 1 | Aug 11, 2010 | clinicaltrials |
| NCT01168323 | Spaced Education to Optimize Prostate Cancer Screening | completed | N/A | 95 | Harvard University Faculty of MedicineOTHER | 1 | Aug 9, 2010 | clinicaltrials |
Data updated 23 days agoSource updated Feb 21, 2011source: clinicaltrials